These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


254 related items for PubMed ID: 16632459

  • 1. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.
    HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
    [Abstract] [Full Text] [Related]

  • 2. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 3. CMV retinitis recurs after stopping treatment in virological and immunological failures of potent antiretroviral therapy.
    Torriani FJ, Freeman WR, Macdonald JC, Karavellas MP, Durand DM, Jeffrey DD, Meylan PR, Schrier RD.
    AIDS; 2000 Jan 28; 14(2):173-80. PubMed ID: 10708288
    [Abstract] [Full Text] [Related]

  • 4. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR, Baldassano VF, Whitcup SM.
    Ophthalmology; 1998 Jul 28; 105(7):1259-64. PubMed ID: 9663231
    [Abstract] [Full Text] [Related]

  • 5. Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy.
    Jouan M, Savès M, Tubiana R, Carcelain G, Cassoux N, Aubron-Olivier C, Fillet AM, Nciri M, Sénéchal B, Chêne G, Tural C, Lasry S, Autran B, Katlama C, RESTIMOP study team.
    AIDS; 2001 Jan 05; 15(1):23-31. PubMed ID: 11192865
    [Abstract] [Full Text] [Related]

  • 6. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 7. Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART.
    Waib LF, Bonon SH, Salles AC, Benard G, de Oliveira AC, Pannuti CS, Pedro Rde J, Costa SC.
    Rev Inst Med Trop Sao Paulo; 2007 Nov 03; 49(4):215-9. PubMed ID: 17823749
    [Abstract] [Full Text] [Related]

  • 8. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 03; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 9. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy.
    Wohl DA, Kendall MA, Owens S, Holland G, Nokta M, Spector SA, Schrier R, Fiscus S, Davis M, Jacobson MA, Currier JS, Squires K, Alston-Smith B, Andersen J, Freeman WR, Higgins M, Torriani FJ, ACTG 379 Study Team.
    HIV Clin Trials; 2005 May 03; 6(3):136-46. PubMed ID: 16192248
    [Abstract] [Full Text] [Related]

  • 10. Results of a cytomegalovirus (CMV)-specific CD8+/interferon- gamma+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis.
    Jacobson MA, Maecker HT, Orr PL, D'Amico R, Van Natta M, Li XD, Pollard RB, Bredt BM, Adult AIDS Clinical Trials Group and the Studies of Ocular Complications of AIDS Research Group.
    J Infect Dis; 2004 Apr 15; 189(8):1362-73. PubMed ID: 15073672
    [Abstract] [Full Text] [Related]

  • 11. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.
    Ophthalmology; 2000 May 15; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [Abstract] [Full Text] [Related]

  • 12. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.
    J Infect Dis; 1998 Apr 15; 177(4):1080-3. PubMed ID: 9534987
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus retinitis after the initiation of highly active antiretroviral therapy: a 2 year prospective study.
    Mitchell SM, Membrey WL, Youle MS, Obi A, Worrell S, Gazzard BG.
    Br J Ophthalmol; 1999 Jun 15; 83(6):652-5. PubMed ID: 10340970
    [Abstract] [Full Text] [Related]

  • 14. Effect of combination antiretroviral therapy on cytomegalovirus retinitis.
    Banker AS, Patel A.
    Indian J Ophthalmol; 2002 Mar 15; 50(1):29-33. PubMed ID: 12090084
    [Abstract] [Full Text] [Related]

  • 15. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR, Jabs DA.
    Herpes; 2007 Dec 15; 14(3):66-71. PubMed ID: 18371289
    [Abstract] [Full Text] [Related]

  • 16. CMVR diagnoses and progression of CD4 cell counts and HIV viral load measurements in HIV patients on HAART.
    Zambarakji HJ, Newson RB, Mitchell SM.
    Br J Ophthalmol; 2001 Jul 15; 85(7):837-41. PubMed ID: 11423459
    [Abstract] [Full Text] [Related]

  • 17. Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient, despite potent antiretroviral therapy and apparent immune reconstitution.
    Johnson SC, Benson CA, Johnson DW, Weinberg A.
    Clin Infect Dis; 2001 Mar 01; 32(5):815-9. PubMed ID: 11229851
    [Abstract] [Full Text] [Related]

  • 18. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan 01; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 19. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
    Tufail A, Moe AA, Miller MJ, Wagar EA, Bruckner DA, Holland GN.
    Ophthalmology; 1999 Jan 01; 106(1):133-41. PubMed ID: 9917794
    [Abstract] [Full Text] [Related]

  • 20. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB, Briggs JW, McDonald JC, Freeman WR, Morse LS.
    Retina; 2001 Jan 01; 21(4):339-43. PubMed ID: 11508879
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.